Trial intelligence / Profile preview

Topical pentoxifylline ointment for bedsore healing

IRCT20150721023282N18Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of pentoxifylline in decubitus ulcer (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Percent decrease in wound size and Complete wound healing. Started Jul 2021; status: completed.

02

Drugs

pentoxifylline
03

Conditions

decubitus ulcer

Beyond the preview

Go deeper on IRCT20150721023282N18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20150721023282N18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call